NCT02908282View on ClinicalTrials.gov

Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

Dry Eye Syndromes

Interventions

DEVICE

REMOGEN OMEGA

Lubricant eye drops: preservative-free, hypotonic microemulsion of polyunsaturated fatty acids and hydrating polymers provided in single-dose containers of 0.25 ml.

DEVICE

Povidone

Artificial tears: preservative-free eye drops containing 2% povidone.

Trial Locations (5)

22459

Dr. Flamm & Böker: Augenärzte am Tibarg, Hamburg

50931

Augenheilkunde Lindenthal, Köln-Lindenthal

69121

Praxis Dr. Kaercher, Heidelberg

80333

Praxis Prof. Dr. Anselm Kampik & Kollegen, Munich

82140

Augenzentrum Olching, Olching

All Listed Sponsors

lead

TRB Chemedica AG

INDUSTRY

NCT02908282 - Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye | Biotech Hunter | Biotech Hunter